Results 131 to 140 of about 46,447 (205)

Safety and efficacy of sotorasib plus panitumumab and FOLFIRI for previously treated KRAS G12C-mutated metastatic colorectal cancer in the CodeBreaK 101 phase Ib study. [PDF]

ESMO Open
Masuishi T, Strickler JH, Kuboki Y, Fakih M, Greil R, Galot R, Price TJ, Élez E, Siena S, Nolte-Hippenmeyer J, Nduka C, Strydom N, Xia C, Hong DS.   +13 more
europepmc   +1 more source

Second-line raltitrexed plus irinotecan (SALIRI) with bevacizumab, cetuximab, or alone for metastatic colorectal cancer: a prospective multicenter cohort-based secondary analysis of the SALLY trial. [PDF]

J Gastrointest Oncol
Kou F, Wang X, Li J, Wang Z, Xu T.
europepmc   +1 more source

NALIRIFOX in Japanese treatment-naïve patients with metastatic pancreatic adenocarcinoma: results from an open-label, phase II study. [PDF]

ESMO Gastrointest Oncol
Ueno M, Ikezawa K, Komatsu Y, Nagano H, Hisano T, Terashima T, Nio K, Morizane C, Shimizu S, Ozaka M, Ohyama H, Otsuru T, Sudo K, Mizuno N, Daniel C, Martín-Fernández L, Amellal N, Bernard K, Sasaki M.   +18 more
europepmc   +1 more source

Irinotecan Modulates Immune Checkpoints in Neuroblastoma. [PDF]

Immunotargets Ther
Lapidus T, Zorde-Khvalevsky E, Jolani A, Goldstein G, Peled A.   +4 more
europepmc   +1 more source

UGT1A1 and irinotecan: Ready for routine pharmacogenetic care. [PDF]

Br J Clin Pharmacol
Swen JJ.
europepmc   +1 more source

Epithelial interferon-stimulated gene programs modulate chemotherapy sensitivity in colorectal cancer via EPSTI1. [PDF]

Oncogene
Erkan EP, Hämäläinen E, Kolikova J, Nikupaavola T, Sajnani K, Kuc K, Ojala K, Kukkonen M, Hermelo I, Kurttila A, Koskensalo S, Tarvainen T, Leppä A, Keränen I, Haapamäki C, Karjalainen E, Carpelan-Holmström M, Renkonen-Sinisalo L, Koskenvuo L, Puolakkainen P, Mecklin JP, Väyrynen JP, Virolainen E, iCAN, Nykter M, Aaltonen LA, Urbanucci A, Lepistö A, Ristimäki A, Seppälä TT.   +29 more
europepmc   +1 more source

Irinotecan-Loaded Vaterite Microspheres for Drug Delivery: Drug Release and Dissolution Kinetics and Mechanism in an Aqueous Solution and Human Serum. [PDF]

Langmuir
Milner MP, Saint HA, Yang JM, Neumann CCM, Wansch K, Compton RG.   +5 more
europepmc   +1 more source

Case Report: cytoreductive prostatectomy after platinum-etoposide chemotherapy for <i>de novo</i> metastatic prostatic small cell neuroendocrine carcinoma. [PDF]

Front Urol
Wang Y, Wang Q, Yang H.
europepmc   +1 more source

Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI Trial. [PDF]

J Clin Oncol
Al-Samkari H, Shatzel JJ, Panch SR, Keating JH, Walsh EP, Weekes CD, Kardosh A, Cohen SA, Cohen JJ, Hodges PG, Dhaver SE, Strojny N, Donovan C, Belibasakis C, Soff GA.   +14 more
europepmc   +1 more source